Helperby Therapeutics Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $619K
Latest Deal Amount
  • Investors
  • 2

Helperby Therapeutics General Information

Description

Developer of antibiotic resistance breakers designed to fight against deadly infections resistant to antibiotics. The company's products include a drug that rejuvenates old antibiotics, killing dormant and multidrug-resistant bacteria, enabling patients to get a unique methodology that allows rejuvenating old antibiotics, making them useful once again in treating infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 66 Lincoln's Inn Fields
  • London WC2A 3LH
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Helperby Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 21-Oct-2015 $619K 000.00 00000 Completed Generating Revenue
3. Later Stage VC 24-Apr-2014 00.000 000.00 000.00 Completed Generating Revenue
2. Angel (individual) 06-Jul-2012 $3.54M $8.01M 000.00 Completed Generating Revenue
1. Angel (individual) 01-Jan-2007 $4.48M $4.48M 000.00 Completed Generating Revenue
To view Helperby Therapeutics’s complete valuation and funding history, request access »

Helperby Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 6 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 5 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 4 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 3 00,000 00.000000 000.00 000.00 00 000.00 0.00
Ordinary 2 82,150 $0.153389 $30.68 $30.68 1x $30.68 4.24%
Ordinary 1 143,771 $0.153389 $23.78 $23.78 1x $23.78 7.41%
To view Helperby Therapeutics’s complete cap table history, request access »

Helperby Therapeutics Patents

Helperby Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2589286-A Method Pending 22-Jul-2019 000000000 0
GB-201709193-D0 Combination Ceased 09-Jun-2017 00000000000
US-20200197480-A1 Combination comprising a particular polymyxin Abandoned 09-Jun-2017 00000000000
CA-3066043-A1 Combination comprising a particular polymyxin Pending 09-Jun-2017 00000000000
GB-201704620-D0 Combinations Ceased 23-Mar-2017 A61K38/12

Helperby Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
James Phipson Interim Chairman & Chief Executive Officer
Micheal Dey Interim Chief Operating Officer
Anthony Coates MD Founder, Chief Scientific Officer & Board Member
Yanmin Hu Ph.D Director Of Research
Craig Williams Finance Director
You’re viewing 5 of 15 executive team members. Get the full list »

Helperby Therapeutics Board Members (7)

Name Representing Role Since
Anthony Coates MD Helperby Therapeutics Founder, Chief Scientific Officer & Board Member 000 0000
James Phipson Helperby Therapeutics Interim Chairman & Chief Executive Officer 000 0000
Kenelm Storey Self Chairman 000 0000
Patrick Mocatta Helperby Therapeutics Board Member 000 0000
Till Medinger Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Helperby Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Helperby Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Metellus Family Office Minority 000 0000 000000 0
Kenelm Storey Angel (individual) Minority 000 0000 000000 0
To view Helperby Therapeutics’s complete investors history, request access »